Bailout Endovascular Retrieval of a Severely Kinked Guiding Catheter During Primary PCI for Inferior STEMI.

Catheter Cardiovasc IntervJul 5, 2026 (epub)
Case ReportCardiologyOpen access

Abdülmelik Birgün, Muhammet Cihat Çelik, Osman Karaarslan et al.

✦ AI-curated · Sources linked

Case in brief

A 75-year-old male with chronic kidney disease presented with inferior ST-segment elevation myocardial infarction and required emergent primary PCI. During the procedure, a 7 F guiding catheter developed severe double-segment kinking. Initial attempts at wire-assisted correction failed, leading to further deformation. A contralateral femoral access was utilized for bailout management, allowing for successful catheter retrieval and revascularization of the right coronary artery.

Diagnostic / clinical pearl

This case underscores the critical role of structured snare-assisted realignment and careful access-site selection in managing severe guiding catheter deformation during urgent PCI.

Source

PubMed · PMID 42402802Free full text on PubMed Central

Published in Catheter Cardiovasc Interv. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.